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Abstract
Background: Plantar heel pain (plantar fasciitis) is one of the most common musculoskeletal pathologies of the
foot. Plantar heel pain can be managed with dry needling and/or injection of myofascial trigger points (MTrPs)
however the evidence for its effectiveness is uncertain. Therefore, we aimed to systematically review the current
evidence for the effectiveness of dry needling and/or injections of MTrPs associated with plantar heel pain.
Methods: We searched specific electronic databases (MEDLINE, EMBASE, AMED, CINAHL, SPORTDiscus and AMI) in
April 2010 to identify randomised and non-randomised trials. We included trials where participants diagnosed with
plantar heel pain were treated with dry needling and/or injections (local anaesthetics, steroids, Botulinum toxin A
and saline) alone or in combination with acupuncture. Outcome measures that focussed on pain and function
were extracted from the data. Trials were assessed for quality using the Quality Index tool.
Results: Three quasi-experimental trials matched the inclusion criteria: two trials found a reduction in pain for the
use of trigger point dry needling when combined with acupuncture and the third found a reduction in pain using
1% lidocaine injections when combined with physical therapy. However, the methodological quality of the three
trials was poor, with Quality Index scores ranging form 7 to 12 out of a possible score of 27. A meta-analysis was
not conducted because substantial heterogeneity was present between trials.
Conclusions: There is limited evidence for the effectiveness of dry needling and/or injections of MTrPs associated
with plantar heel pain. However, the poor quality and heterogeneous nature of the included studies precludes
definitive conclusions being made. Importantly, this review highlights the need for future trials to use rigorous
randomised controlled methodology with measures such as blinding to reduce bias. We also recommend that
such trials adhere to the Standards for Reporting Interventions in Controlled Trials of Acupuncture (STRICTA) to
ensure transparency.
Background
Plantar heel pain (plantar fasciitis) is one of the most
common musculoskeletal pathologies of the foot. It is
estimated to affect 10% of the population at some time
in their life [1], although there are few high quality epi-
demiological studies available. One national study of
medical doctors in the United States during the years
1995 to 2000 found that approximately one million
patient visits to physicians per year were for plantar heel
pain [2]. In addition, a recent Australian study of 3206
adults found that approximately 20.9% (95% CI 17.7 to
24.45) indicated that they had heel pain, although this
study did not differentiate between plantar heel pain
and pain in other parts of the heel [3].
Plantar heel pain is generally accepted to predomi-
nantly affect middle aged as well as older adults. In a
study of 784 North American community-dwelling resi-
dents aged 65 years or greater, 7% reported pain and
tenderness beneath the heel [4]. Although plantar heel
pain affects older adults, some other groups are also vul-
nerable. For example, it is also common in the athletic
population, being estimated to contribute to 25% of all
foot injuries related to running [5]. Plantar heel pain has
been shown to have an impact on health-related quality
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ence social isolation; have a poor perception of their
health status; are severely limited in their ability to
undertake physical activities and lack the energy to
undertake daily tasks [6].
Numerous interventions are used to treat plantar heel
pain including calf stretching, foot taping, manual ther-
apy (joint mobilisation and manipulation; mobilisation
of soft tissue near sites of nerve entrapment and passive
neural mobilisation techniques) foot orthoses, oral and
injectable anti-inflammatories and night splints [7]. Sur-
gery is recommended as a last resort and usually only
after failure of at least six months of conservative ther-
apy [8]. Clearly there are many interventions used to
treat plantar heel pain, but the Clinical Practice Guide-
lines for plantar heel pain proposed by the Orthopaedic
Section of the American Physical Therapy Association
do not recommend one treatment over another [7].
Furthermore, two systematic reviews [9,10] have found
few interventions that are supported by good evidence.
An alternative treatment for plantar heel pain involves
dry needling and/or injections (local anaesthetics, steroids,
Botulinum toxin A and/or saline) of myofascial trigger
points (MTrPs) within the lower limb and foot. However,
the aforementioned systematic reviews [9,10] did not iden-
tify any clinical trials that have investigated the effective-
ness of dry needling and/or injections of MTrPs.
Therefore, we aimed to systematically review the literature
evaluating the effectiveness of dry needling and/or injec-
tions of MTrPs associated with plantar heel pain.
Methods
Types of studies
All clinical trials included in this review were obtained
from peer-reviewed journals investigating thee f f e c t i v e -
ness of dry needling and/or injections of MTrPs asso-
ciated with plantar heel pain. Randomised controlled
and quasi-experimental (an experiment that lacks either
randomisation of participants or control group(s) or
both) trials examining the effectiveness of trigger point
dry needling and/or injections for plantar heel pain were
included. The decision to include quasi-experimental
trials was based on the lack of randomised controlled
trials to draw evidence from; hence we attempted to
obtain an overview of what was known to date. Includ-
ing non-randomised trials in systematic reviews can be
appropriate when there are a limited number of rando-
mised trials available [11]. Further, Linde et al.[12] con-
ducted a systematic review of randomised and non-
randomised trials that evaluated the effectiveness of acu-
puncture for chronic headache and found that non-ran-
domised trials of good quality yielded positive responses
to treatment that were similar to randomised-controlled
trials. The authors concluded the inclusion of high
quality non-randomised controlled trials into a systema-
tic review might add to the generalisability of the find-
ings. Letters to the editor, opinion pieces and editorials
were excluded.
Types of participants
A clinical trial was included if the participants were
diagnosed with plantar heel pain. All participants were
over the age of 18 and had experienced symptoms of
any duration. A trial was only included if the partici-
pant’s plantar heel pain was managed by treatment of
MTrPs in the lower extremity and/or foot. The rationale
for this decision was based on the assumption that
some forms of plantar heel pain might occur secondary
to MTrPs in plantar heel muscles (i.e. abductor hallucis
and quadratus plantae) and/or referred pain from the
soleus muscle [13]. A trial was excluded if the partici-
pant’s plantar heel pain was associated with a vascular
or neurological disease, arthritis (degenerative and
inflammatory) or fibromyalgia.
Types of Intervention
Clinical trials were included if they investigated the
effectiveness of dry needling and/or injections (local
anaesthetics, steroids, Botulinum toxin A and/or saline)
of MTrPs for plantar heel pain. Trials were excluded if
they involved needling of traditional acupuncture points
as the sole treatment because the relationship between
traditional acupuncture points and MTrPs is unclear
[14]. However, it has been suggested that there might be
a correlation between MTrPs and a class of acupuncture
points referred to as Ah Shi points (pain points). Ah Shi
points are a class of acupuncture points positioned out-
side the traditional Chinese meridians and are com-
monly treated by traditional acupuncturists for painful
conditions including muscle spasm [15]. Given the
uncertainty of this relationship, we included trials that
utilised acupuncture only if it was combined with dry
needling or injection of MTrPs.
Types of outcome measures
A trial was included if any of the following primary out-
come measures were used: Visual Analogue Scale; The
Foot Health Status Questionnaire; The Foot Function
Index or any other health-related quality of life measure.
Secondary outcome measures investigating physiological
changes (e.g. joint range of motion and pressure pain
threshold) following the intervention were included pro-
viding at least one of the aforementioned primary out-
come measures was reported.
Search methods for identification of studies
In April 2010 the following electronic databases were
used to search the literature: Ovid MEDLINE (1950 to
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(from inception), CINAHL (1982 to date), SPORTDiscus
(from inception) and AMI (1968 to date). A full electro-
nic search strategy from the EMBASE database is
included in Table 1.
In addition, experts in the field of MTrP therapy were
questioned about their knowledge of further articles not
captured in the database search. The reference lists of
all included articles were hand searched for trials meet-
ing the inclusion criteria. Finally, Google Scholar and
SUMsearch were searched for grey literature (informa-
tion that has not been published, or if published is not
readily accessible). No language restrictions were
applied.
Study selection
Two investigators (MC and an impartial assessor) inde-
pendently scanned the title and abstracts for informa-
tion fulfilling the inclusion criteria. If a decision could
not be made it was retained until the full text was
obtained. A full text of all potentially eligible articles
was then accessed and reviewed by both assessors to
ensure eligibility. Discrepancies between the two
reviewers were resolved using a third assessor (KBL).
Data Extraction
A data extraction form (see Additional File 1) was modi-
fied from an existing standardised extraction form pro-
duced by the Centre for Reviews and Dissemination
[16]. The content of the form included topics relevant
to acupuncture and trigger point dry needling research
as recommended by the Standards for Reporting Inter-
ventions in Controlled Trials of Acupuncture
(STRICTA) [17]. Relevant data (means, mean differ-
ences, standard deviations, and p values) were extracted
from the selected articles by two of the investigators
(MC and SEM). Any disagreement between the authors
was discussed with KBL and a general consensus agreed
upon.
Assessment of methodological quality
Two reviewers (MC and an impartial assessor) indepen-
dently assessed the methodological quality of the
included articles using the Quality Index (QI) [18] tool,
which has been shown to have high internal consistency
(KR-20: 0.89), good test-retest reliability (r = 0.88) and
inter-rater reliability (r = 0.75). The original Quality
Index is a 27-point checklist which covers four domains:
internal validity, external validity, reporting and power.
The literature has not established cut off values for the
Quality Index methodological quality assessment tool.
Downs and Black [18] (p. 381) stated that"the value of a
single global score needs to be tested by reviewers mak-
ing such an assessment before rather than after using
the 27 item checklist”. The use of a single summary
score or global score has been criticised in the literature
as it might eliminate sources of heterogeneity among
the results [19].
For this systematic review, three items were modified.
First, for Item 10, two points were allocated to trials
that utilised confidence intervals as well as p values for
the main outcomes as confidence intervals provide more
information regarding the magnitude and precision of a
treatment effect [20]. Second, Item 25 was removed as it
has been shown that case mix adjustment cannot reduce
the extent of bias in non-randomised trials [19]. Finally,
Item 27 was removed as a minimally important differ-
ence using the visual analogue scale has not been calcu-
lated for MTrP interventions in participants with
plantar heel pain.
Results
A total of 342 studies were identified through database
and other sources. Following inspection of the titles and
abstracts, 334 were excluded. Of the 8 remaining stu-
dies, a full text of unpublished data (identified from con-
ference abstracts) by Imamura et al. (2003) and
Sconfienza (2008) could not be obtained from the
authors. Further analysis of the full text from the
Table 1 A full electronic search strategy from the
EMBASE database, April, 2010
# Searches
1 exp Lower Extremity/
2 exp Therapeutics/
3 exp Myofascial Pain Syndromes/
4 exp"Outcome and Process Assessment (Health Care)"/or exp"Quality
of Life"/or exp"Outcome Assessment (Health Care)"/or exp
Questionnaires/or exp Treatment Outcome
5 exp Heel Pain/or exp Pain Assessment/or exp Foot Pain/or exp
Musculoskeletal Pain/
6 exp fasciitis/
7 exp methodology/
8 (leg* or calf or calves or foot or feet or ankle* or toe* or plantar
fascia or plantar aponeurosis or plantar ligament or area).mp.
9 (needl* or acupuncture or inject*)
10 (trigger area* or trigger point* or"myofascial trigger point pain”
or"myofascial pain components” or taut band).
11 (systematic review or"randomised controlled trial” or RCT or qausi
experimental or"single subject design” or comparative study)
12 VAS or"visual analogue scale” or"visual analysis scale” or"activities of
daily living” or"quality of life” or"pressure pain threshold” or
algometry
13 9 or 2
14 6 or 3 or 10
1 5 5o r1 2o r4
16 11 or 7
17 1 or 8
18 13 and 14 and 15 and 16 and 17
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the inclusion criteria (Table 2) and 3 trials were
excluded [21-23]. A flow diagram of the study selection
process is presented in Figure 1.
Quality of the evidence
The inter-rater reliability of total Quality Index scores
was not calculated due to the small number of trials
included. Perfect agreement was recorded on all items
except question 4 where there was 67% agreement
between the assessors.
Table 3 presents the results from the quality assess-
ment. All included studies were of a poor methodologi-
cal quality. The total score of the Quality Index ranged
from 7/27 to 12/27 with a mean Quality Index score of
10/27 across the three trials. The internal validity
domain rated most poorly across the trials due to the
presence of selection [24-26], detection [24], statistical
[24], performance [24-26] and attrition bias [24]. In
addition, all three trials used secondary outcome mea-
sures that were not valid and reliable.
Trial characteristics
All trials had a quasi-experimental design with pre-test
and post-test measures. Imamura et al.[24] conducted
a quasi-experimental trial with a non-randomised con-
trol group to evaluate the effectiveness of 1% lidocaine
injections of MTrPs in combination with physical
Table 2 Characteristics of included studies
Trial Design Number allocated to
experimental and control
groups
Mean age
in
years (SD)
%
Female
Mean
duration
of disease in
months (SD)
Exclusion
criteria
Criteria used to
identify the
MTrP
Tillu and
Gupta
(1998)
Quasi-
experimental
(one group)
Experimental = 18 49.1 (10.7) 72.3% 25.1 (10.7) History of heel
surgery
or cortisone injection
in
last three months
No criteria used
Imamura
et al.
(1998)
Quasi-
experimental
(two groups,
non-randomised)
Experimental = 15
(Actual number is unclear
but it
would appear that 20 were
recruited and 5 dropped
out)
Control = 9 at discharge.
Experimental:
50.0 (12.2)
Control:
44.0 (NR)
89.7% 27.0 (NR) NR MTrP identified
via
palpation (local
tenderness and
taut
band)
Perez-
Millan
and Foster
(2001)
Quasi-
experimental
(one group)
Experimental = 11 39.5 (12.7) 72.8% 39.0 (5.0) NR NR
Key: NR=Not reported
Figure 1 Flow of information through the systematic review.
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and leg (Table 4). The physical therapy component
included heat application for 20 minutes and faradic
stimulation over the area treated for another 20 min-
utes. Stretching exercises were prescribed (3 times per
day for 15 seconds) after heat application. In addition,
relaxation exercises were issued to some participants if
required. In contrast, the control group received con-
ventional therapy, although the details were not
included.
Table 3 Evaluation of trial quality
Quality Index items Imamura et
al. (1998)
Tillu and
Gupta (1998)
Perez Millan and
Foster (2001)
Reporting
1. Study hypothesis/aim/objective 1 1 1
2. Main outcomes 11 1
3. Characteristics of the participants 0 0 0
4. Interventions of interest 0 1 0
5. Distributions of principal confounders in each group 0 0 0
6. Main findings 01 1
7. Estimates of random variability for main outcomes 1 0 1
8. All the important adverse events that may be a consequence of intervention 0 0 0
9. Characteristics of patients lost to follow-up 0 1 1
10. Actual probability values for main outcomes 0 1 0
External validity
11. Were subjects who were asked to participate representative of the entire population
from which they were recruited?
11 0
12. Were subjects who were prepared to participate representative of the entire population
from which they were recruited?
00 0
13. Were the staff, places, and facilities representative of the treatment the majority of
subjects received?
10 1
Internal validity (bias)
14. Was an attempt made to blind subjects to the intervention they received? 0 0 0
15. Was an attempt made to blind those measuring main outcomes of the intervention? 0 0 0
16. If any of the results of the study were based on"data dredging”, was this made clear? 0 1 1
17. Do analyses adjust for different lengths of follow-up? 0 1 1
18. Were appropriate statistical tests used to assess the main outcomes? 1 1 1
19. Was compliance with the intervention reliable? 1 1 1
20. Were main outcome measures reliable and valid? 0 0 0
Internal validity (selection bias)
21. Were patients in different intervention groups recruited from the same population? 0 0 0
22. Were subjects in different intervention groups recruited over the same period of time? 0 0 0
23. Were subjects randomized to intervention groups? 0 0 0
24. Was the randomized intervention assignment concealed from both patients and staff
until recruitment was complete and irrevocable?
00 0
* 25. Was there adequate adjustment for confounding in the analyses from which main
findings were drawn?
xx x
26. Were losses of subjects to follow-up taken into account? 0 1 1
Power
* 27. Did the study have sufficient power to detect a clinically important effect where the
probability for a difference due to chance was less than 5%?
xx x
Total score (/27) 7 12 11
Instructions for use
For Q 1-9 one point is allocated for Yes and zero points for No.
For Q 5 two points are allocated for Yes, one point for Partially and zero points for No.
For Q 10 two points are allocated for Yes, one point for Partially and zero points for No.
For Q 11-27 one point is allocated for Yes, zero points for No and zero points for Unable to Determine.
* Item removed.
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four-week course of traditional acupuncture followed by
at w o - w e e kc o u r s eo ft r i g g e rp o i n td r yn e e d l i n gc o m -
bined with acupuncture. This trial was not a cross-over
design in the strict sense, rather all participants received
the course of treatment in the same order. In contrast,
Perez-Millan and Foster [26] investigated the effective-
ness of trigger point needling combined with electro-
acupuncture. Tillu and Gupta [25] and Perez-Millan and
Foster [26] did not include a control group for compari-
son (refer to Table 4 for a description of the trigger
point dry needling and injection details).
The characteristics used to identify a MTrP were not
described by Tillu and Gupta [25] or Perez-Millan and
Foster [26], however Imamura et al. [24] used the
common criteria of a taut band and local tenderness to
diagnose a MTrP. In addition, three trials varied in; the
muscles that were treated; the size and type of needles
used; the response elicited, and the duration of needle
insertion. The treatment schedules were generally simi-
lar across the trials with weekly treatments for a period
of six weeks. All three trials used a visual analogue
scale as the primary outcome measure, although there
was variability in the secondary outcome measures
used.
Evidence for the effectiveness of dry needling and/or
injections of MTrPs associated with plantar heel pain
As clinical heterogeneity of the included trials was evi-
dent the findings of the included studies were combined
using a narrative rather than a quantitative approach. As
such, meta-analysis was not performed. Table 5 provides
a detailed description of the mean differences between
and within groups for the trial by Imamura et al. [24]
and mean differences within groups for Tillu and Gupta
[25] and Perez-Millan and Foster [26].
Imamura et al. [24] found a statistically significant
decrease in pain for the use of 1% lidocaine injections
and standard therapy for the MTrP injection group at
discharge (58.4% improvement, p = 0.003), six months
(67.1% improvement, p = 0.007) and two years (67.1%
improvement, p = 0.002). Similarly, a statistically
Table 4 Types of interventions, treatment regime and outcome measures
Trial Intervention Trigger points and
Acupuncture
points selected for treatment
Outcome measure Number of treatment
sessions
per week
Tillu and
Gupta
(1998)
25 mm acupuncture needle
(diameter
unknown) inserted for 15 minutes
and
stimulated every 5 minutes for 5
sec.
Needle was manipulated to
produce
de qi. No control group.
(i) Acupuncture points KI.3;
BL.60 and SP.6
(ii) Gastrocnemius MTrP and heel
MTrP. Specific location of MTrP in
the heel and calf not identified.
(i) Visual analogue scale
(ii) Verbal pain score
Outcome measures
recorded
at 4 and 6 weeks post
baseline.
4 sessions of acupuncture/
1 per
week. If symptoms were not
resolved after this period,
2 sessions (1 per week) of
acupuncture and dry
needling were implemented.
Imamura
et al.
(1998)
22-25 gauge needle repetitively
inserted
and withdrawn with injection of 1%
lidocaine into the MTrP; plus
*standard
therapy. Control group received
conventional conservative therapy
but
not outlined in the methods.
Medial head of Gastrocnemius;
Soleus; Tibialis posterior;
Popliteus; Abductor hallucis;
Peroneus Longus and Flexor
digitorum brevis
(i) Duration of treatment
(ii) Visual analogue scale
(iii) Pressure pain threshold
Outcome measures
recorded
at discharge, 6 and 24
months
The number of sessions and
times per week varied
between the groups
Perez-Millan
and Foster
(2001)
10-120 mm acupuncture needle
(0.20-0.25 mm diameter); plus
electrostimulator (2-4 Hz)
for 20-30 minutes. No control
group.
(i) Acupuncture points KI.1, 3, 6;
BL.60, 67; GB 44
(ii) MTrPs points in the heel and
arch
regions
(i) Visual analogue scale
(ii) **Foot function index
questionnaire
Outcome measures
recorded
at 6 weeks post baseline
6 sessions/1 per week
Key:
MTrP = myofascial trigger point.
*Standard therapy = implemented once per day for three days following the injection: included: (i) heat (20min) and faradic stimulation over affected area for 20
min, (ii) stretching for three days, 3 times per day for 15 seconds after hot pack application, (iii) participants advised to avoid walking and standing for two days
post injection.
** Foot function index questionnaire used in this trial was not validated.
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group at discharge (54.9% improvement, p < 0.05, the
exact p value was not reported); however there was no
follow-up at six months or two years for this group.
Imamura et al. [24] found a statistically significant
decrease in the duration of treatment between the injec-
tion and control groups (3.4 weeks versus 21.1 weeks
respectively). Importantly the only between-group com-
parison made in this trial was for the total duration of
treatment.
The other two trials by Tillu and Gupta [25] and
Perez-Millan and Foster [26] only included a treatment
group and no comparison was made to a control group.
Nevertheless, Tillu and Gupta [25] observed a statisti-
cally significant improvement in pain for a two-week
course of dry needling and acupuncture when compared
to a previous four-week period of acupuncture treat-
ment (p = 0.047). Finally, Perez-Millan and Foster [26]
found a significant improvement in pain for the use of
dry needling and electro-acupuncture (p < 0.001).
Discussion
The aim of this study was to conduct a systematic
review of the literature to evaluate the evidence for the
effectiveness of dry needling and/or injections of MTrPs
associated with plantar heel pain. The search strategy
found three quasi-experimental trials. One trial com-
pared the effectiveness of 1% lidocaine injections com-
bined with standard therapy to standard therapy alone.
A second trial evaluated the effectiveness of trigger
point dry needling combined with electro-acupuncture,
whereas a third trial evaluated the effectiveness of
Table 5 Mean differences between and within groups of included studies
Trial Difference between
groups
Differences within groups
Tillu and
Gupta
(1998)
N/A (one group only) (i) VAS pain:
@ 4 weeks (34.7% improvement, p < 0.001)
@ 6 weeks (67.9% improvement, p < 0.001)
@ 6 weeks vs 4 weeks, (difference 33.2%, p = 0.047)
(ii) Verbal pain score (% of improvement):
40.2 (40.1%) @ 4 weeks and 65.9 (32.8%) @ 6
weeks
Intervention Control
Imamura
et
al. (1998)
Duration of treatment
(weeks): Significantly
less in intervention
group (83.9% difference
between the groups,
p < 0.05)
(i) Mean duration of treatment in weeks (SD)
(ii) VAS pain:
@ discharge
@ 6 months
@ 2 years
3.4 (2.2)
58.4% improvement,
p = 0.003
67.1% improvement,
p = 0.007
67.1% improvement
p = 0.002
21.1 (19.5)
54.9% improvement, p < 0.05
values not reported at 6
months
values not reported at 12
months
(iii) PPT (gastrocnemius):
@ discharge
@ 6 months
@ 2 years
130% increase, p =
0.001
71% increase, p =
0.009
55% increase, p =
0.023
PPT not reported for control
(iv) PPT (medial calcaneal tubercle) at:
@ discharge
@ 6 months
@ 2 years
106% increase, p =
0.004
values not reported at
6
months
143% increase, p =
0.007
PPT not reported for control
Perez-
Millan
and Foster
(2001)
N/A (one group only) (i) VAS pain:
@ 6 weeks (46% improvement, p < 0.001)
(ii) Foot function index questionnaire scores*:
significantly less pain for 10 out of 12
Key: N/A: Not applicable; VAS = visual analogue scale; MTrP = Myofascial trigger point; PPT = Pressure pain threshold; *The foot function index questionnaire
used in this trial was not validated
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bined with trigger point dry needling. However, it is
i m p o r t a n tt on o t et h a ta l lt r ials were of poor methodo-
logical quality.
There were two major reasons for the low quality of
the included trials. First, the internal validity of all three
trials was potentially threatened. Tillu and Gupta [25]
and Perez-Millan and Foster [26] did not include a con-
trol to compare the intervention to and therefore, the
relationship between the dependent and independent
variable might have been influenced by non-intervention
effects, such as the natural course of the disorder. Ima-
mura et al. [24] did compare the intervention to a con-
trol, however there was no evidence that the
participants were randomised. Consequently, the two
groups might not have been equivalent at baseline mak-
ing it difficult to determine if the outcomes were a
reflection of the intervention or differences in prognos-
tic characteristics of the two groups at baseline. The
internal validity of the trial by Imamura et al. [24] might
have also been threatened due to a 25% loss of partici-
pants at discharge. As there was no reference to an
intention-to-treat analysis the characteristics of the two
groups may have become different as the trial pro-
gressed, which could have affected the estimate of the
treatment effect. Further threats to internal validity
might have occurred in all three trials, as no attempt
was made to blind those responsible for measuring the
outcomes.
Second, reporting of the trial rationale [24-26], eligibil-
ity criteria [25,26], study population [24-26], details of
the researcher’s background [24-26], needling and injec-
tion details [24-26], control intervention [24], and
results [24-26], were all incomplete. Imamura et al. [24]
did provide details of the muscles that were injected,
however there was insufficient information which mus-
cles were treated during each session, the number of
injections (total and per muscle), and the depth of nee-
dle insertion. In addition, Tillu and Gupta [25] and
Perez-Millan and Foster [26] did not report which mus-
cles were dry needled in the foot, the number of needles
inserted into a MTrP, the depth of needle insertion, or
the needle response elicited during dry needling of a
MTrP. The presence of a local twitch response during
trigger point dry needling is suggested to help confirm
the presence of a MTrP and is associated with a positive
therapeutic outcome [27]. Furthermore, sensations
described by the patient as a result of needling might be
predictive of the analgesic response [28].
The reporting in two trials also failed to provide suffi-
cient detail of the criteria used to identify a MTrP.
W h i l eI m a m u r ae ta l .[ 2 4 ]u s e dt h ec o m m o nc r i t e r i ao f
at a u tb a n da n dl o c a lt e n d e r n e s st od i a g n o s eaM T r P ,
Tillu and Gupta [25] and Perez-Millan and Foster [26]
did not provide any information regarding the diagnosis
of a MTrP. As there is considerable variability in the cri-
teria used to identify MTrPs [29] and the reliability of
trigger point palpation has not been reported in the
lower extremity and foot, it is imperative that research-
ers outline detailed diagnostic criteria used to identify
MTrPs [29]. This would ensure that the methods used
to diagnose MTrPs is transparent and can be
reproduced.
This systematic review has a number of implications
for further research. First, to reduce bias it is essential
that when evaluating the effectiveness of dry needling
and/or injections of MTrPs associated with plantar heel
pain that rigorous randomised controlled trial (RCT)
methodology be used. In addition, future RCTs should
be designed based on criteria that are recognised for the
quality assessment of randomised controlled trials [30].
Second, it is necessary that outcome measures used are
reliable and valid and include both foot specific and
generic measures [31]. Finally, it is highly recommended
that the Standards for Reporting Interventions in Con-
trolled Trials of Acupuncture (STRICTA) be used to
ensure transparency. This should also include detailed
information about the criteria used to identify the pre-
sence of a MTrP as there is substantial variability in the
criteria used. This will ensure that such trials include
sufficient information for the methodology to be cri-
tiqued and allow comparisons to be made with similar
investigations.
This systematic review also needs to be viewed in light
of some limitations. Two of the included trials [25,26]
combined trigger point dry needling with acupuncture.
While the two techniques have a number of similarities
they are vastly different conceptually. Furthermore, an
assessment of the effectiveness of trigger point dry need-
ling and/or injections might be problematic when it is
combined with acupuncture as it makes it difficult to
isolate the effectiveness of either technique. Hence, the
results can only be generalised to people with plantar
heel pain where both interventions are implemented.
Conclusions
This systematic review found limited evidence for the
effectiveness of dry needling and/or injections of MTrPs
associated with plantar heel pain. However, the quality
of the included trials was poor and serious threats to
internal validity were evident. In addition, the reporting
of the methodology in these trials was inadequate,
which limits comparisons with other investigations. As
such it would be impossible to replicate these studies.
Future trials in this area need to be parallel-group ran-
domised controlled trials that contain adequate mea-
sures to reduce bias. Finally, it is strongly recommended
that trials investigating the effectiveness of trigger point
Cotchett et al. Journal of Foot and Ankle Research 2010, 3:18
http://www.jfootankleres.com/content/3/1/18
Page 8 of 9dry needling and/or injections provide detailed reporting
consistent with the Standards for Reporting Interven-
tions in Controlled Trials of Acupuncture (STRICTA).
Additional material
Additional file 1: Data extraction form. Additional file 1 contains a
copy of the form used to extract data from the studies included in this
systematic review.
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